UNSPSC 51282948: Tosufloxacin

This classification denotes a quinolone antibiotic with the molecular formula C19H15F3N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GHJ553KQPS, chemically known as 1,8-naphthyridine-3-carboxylic acid, 1,4-dihydro-7-(3-amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo- but generally known as tosufloxacin, which bears US NIH Compound Identifier 5517. European Medicines Agency schedules Tosufloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11201MIG.

UNSPSC 51282948 Tosufloxacin is a Commodity code that nominally describes a specific fluoroquinolone antibiotic, but recent state and local procurement activity under this code shows minimal direct alignment with the product name. The Illinois Department of Public Health's August 2026 piggyback pharmaceutical contract through MMCAP Infuse (awarded to Chartwell Rx LLC for $2.999 million over three years) procured Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets via an Invitation for Bid, not Tosufloxacin specifically. Similarly, Seminole County, Florida's June 2026 IFB for Naloxone and Safe Drug Deactivation Systems addresses public health supply chains rather than the antibiotic class the code nominally covers. State and local health departments and counties appear to be the primary issuing bodies using this code designation, though the actual pharmaceutical products being solicited diverge substantially from the code's product name.

The geographic spread of recent activity includes Illinois and Florida. The code shows limited direct purchasing activity for Tosufloxacin itself; instead, state and local procurement offices are tagging broader pharmaceutical warehouse contracts and emergency-response medical supplies under this designation. The Illinois award involved 12-month initial terms with two-year renewal options and quarterly-to-as-needed delivery schedules typical of state health department pharmaceutical procurement, while the Seminole County opportunity required quarterly deliveries of emergency-response medical products. Both opportunities utilized competitive bidding formats and included standard compliance requirements such as drug-free workplace certification and E-Verify validation. The mismatch between the code name and actual solicitation content suggests this code may be used inconsistently or as a catch-all within state procurement taxonomies for certain pharmaceutical categories rather than for Tosufloxacin purchases specifically.